Fundraising Fox
Tiba Aynechi
InvestorGeneral Partner at Norwest Venture Partners · Board director at Rezo Therapeutics · Board director at Ray Therapeutics · Board director at Aristea Therapeutics
San Francisco Bay Area
Writes $10M – $30M checks
Find your path to Tiba
313 people in our graph can introduce you to Tiba.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Heath Lukatch to introduce you to Tiba
You →Heath · together at Cianna Medical (2011–2015) →Tiba
Ask Jamie Chen to introduce you to Tiba
You →Jamie · 2 people · together at Cianna Medical →Tiba
Ask Sam Okafor to introduce you to Tiba
You →Sam · 2 people · together at BioClin Therapeutics →Tiba
Sign up to find every way you can get introduced to Tiba
- Your email: the people you already email who know Tiba
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Tiba
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Tiba Aynechi is a biotech investor at Norwest Venture Partners, investing in healthcare with a focus on early- to mid-stage therapeutics companies. She previously spent over a decade at Novo Holdings A/S, where she deployed roughly $280 million into private biotech, MedTech, and HCIT companies, and earlier worked as a banker on biotech/pharma M&A, licensing, and financing transactions. She holds a bachelor of science in physics with a biomedical concentration from UC Irvine and a Ph.D. in biophysics from UC San Francisco, where she also completed a postdoctoral fellowship.
Likely email· guessed from name + firm domain, not firm-published
- t•••@nvp.comreveal80% confident
Invests in
BiotechConsumerDigital HealthEnterprise SoftwareFintechHealthtechMedical Devices
Board director at Rezo Therapeutics
Intro paths
In turn, Tiba can intro founders to Rezo Therapeutics's investors below.
Rezo Therapeutics's investors · 7
Co-founders at Rezo Therapeutics
Board director at Ray Therapeutics
Intro paths
In turn, Tiba can intro founders to Ray Therapeutics's investors below.
Ray Therapeutics's investors · 10
Co-founders at Ray Therapeutics
Board director at Aristea Therapeutics
Intro paths
In turn, Tiba can intro founders to Aristea Therapeutics's investors below.
Experience
- Norwest Venture PartnersGeneral Partnercurrent2021 — presentSan Francisco Bay Area
- Mosanna TherapeuticsMember Board of Directorscurrent2025 — present
- Engrail TherapeuticsMember Board of Directorscurrent2024 — present
- Ray Therapeutics, Inc.Member Board of Directorscurrent2023 — present
- MBX Biosciences, Inc.Member Board of Directorscurrent2022 — present
- Rezo TherapeuticsMember Board of Directorscurrent2022 — present
- Spruce BiosciencesMember Board Of Directorscurrent2016 — presentSan Francisco Bay Area
- Avalyn PharmaceuticalsMember Board Of Directors2017 — 2026San Diego / Seattle
- Nkarta Therapeutics, IncMember Board Of Directors2015 — 2022South San Francisoc, CA
- Aristea TherapeuticsMember Board Of Directors2018 — 2021
- Novo VenturesSenior Partner2010 — 2021
- ArcellxMember Board of Directors2015 — 2021
- Mirum PharmaceuticalsMember Board Of Directors2018 — 2021Greater San Diego Area
- MDLIVE, an Evernorth companyMember of the Board of Directors2018 — 2021
- Cianna Medical, Inc.Member of Board of Directors2011 — 2018Aliso Viejo, CA
- iRhythm Technologies, Inc.Member Board of Directors2014 — 2017San Francisco Bay Area
- AnaptysBioMember Board Of Directors2015 — 2017Greater San Diego Area
- HTG Molecular DiagnosticsBoard Observer2011 — 2015
- BioClin TherapeuticsMember Board of Directors2014 — 2015San Francisco Bay Area
- Nevro CorporationBoard Observer2013 — 2014Menlo Park, CA
Deals · 10
Spruce BiosciencesBoard seat
via Norwest Venture Partners · filed Oct 2025 · $50M raise
Rezo TherapeuticsBoard seat
via Norwest Venture Partners · filed Aug 2025 · $80.1M raise
Genoa PharmaceuticalsBoard seat
via Norwest Venture Partners · filed Oct 2023 · $189.2M raise
Ray TherapeuticsBoard seat
via Norwest Venture Partners · filed May 2023 · $100M raise
Aristea TherapeuticsBoard seat
via Norwest Venture Partners · filed Aug 2021 · $63.1M raise
Mirum PharmaceuticalsBoard seat
via Norwest Venture Partners · filed Dec 2020 · $10M raise
ArcellxBoard seat
via Norwest Venture Partners · filed Oct 2019 · $83.7M raise
Nkarta, Inc.Board seat
via Norwest Venture Partners · filed Sep 2019 · $114.6M raise
AnaptysBioBoard seat
via Norwest Venture Partners · filed Jul 2015 · $40.8M raise
IrhythmtechBoard seat
via Norwest Venture Partners · filed Mar 2015 · $29.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Norwest Venture Partners
Frequently asked questions
- Who is Tiba Aynechi?
- Tiba Aynechi is a biotech investor at Norwest Venture Partners, investing in healthcare with a focus on early- to mid-stage therapeutics companies. She previously spent over a decade at Novo Holdings A/S, where she deployed roughly $280 million into private biotech, MedTech, and HCIT companies, and earlier worked as a banker on biotech/pharma M&A, licensing, and financing transactions. She holds a bachelor of science in physics with a biomedical concentration from UC Irvine and a Ph.D. in biophysics from UC San Francisco, where she also completed a postdoctoral fellowship.
- Where does Tiba Aynechi work?
- Tiba Aynechi is General Partner at Norwest Venture Partners and Board director at Rezo Therapeutics and Board director at Ray Therapeutics and Board director at Aristea Therapeutics.
- What does Tiba Aynechi invest in?
- Tiba Aynechi invests in Biotech, Consumer, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices.
- What check size does Tiba Aynechi write?
- Tiba Aynechi typically writes checks of $10M – $30M.
- What boards does Tiba Aynechi sit on?
- Tiba Aynechi holds tracked board seats at AnaptysBio, Arcellx, Aristea Therapeutics, Genoa Pharmaceuticals, Genoa Pharmaceuticals, Irhythmtech, MBX Biosciences, Mirum Pharmaceuticals, Nkarta, Inc., Ray Therapeutics.
- Where did Tiba Aynechi go to school?
- Tiba Aynechi studied at University of California, San Francisco (Ph.D., Graduate Group in Biophysics); UC Irvine (BS, Physics).
Same school
Also attended University of California, San Francisco177
+ 171 more
Also attended UC Irvine275
+ 269 more
Shared employers
Also worked at MBX Biosciences, Inc.3
Also worked at Nkarta Therapeutics, Inc3
Also worked at Mirum Pharmaceuticals10
+ 4 more
Also worked at MDLIVE, an Evernorth company8
+ 2 more